PROSTACYCLIJN VERSUS HEPARIN AS ANTICOAGULANT IN CONTINUOUS VENO-VENOUS HEMODIAFILTRATION - ND
- Conditions
- Acute renale failure in intensive unitMedDRA version: 9.1Level: LLTClassification code 10038436Term: Renal failure acute
- Registration Number
- EUCTR2007-004426-24-IT
- Lead Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Patient with acute renal failure admitted to the Intensive Care Unit of our hospital requiring renal replacement therapy according to the latest international guidelines
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
H.they do not fulfil the inclusion criteria
I.they are less than 18 years old
J.they are pregnant women
K.they have been treated with another experimental drug or device within 30 days before the admission to the present study
L.they are positive to HIV infection
M.they have been presenting an haemorrhage in the la test 24 hours
N.they are thrombocytopenic (platelets count less than 30,000 cells/mm3)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: to verify the feasibility and efficacy of prostacyclin versus heparin as antihemostatic agent during veno-venous hemodiafiltration (CVVHDF).;Secondary Objective: Monitoring effects of PROSTACYCLIJN on th platelets;Primary end point(s): nd
- Secondary Outcome Measures
Name Time Method